会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明申请
    • PUPPY TRAINING PAD
    • PUPPY训练垫
    • US20120132146A1
    • 2012-05-31
    • US13296556
    • 2011-11-15
    • Gang Cheng
    • Gang Cheng
    • A01K29/00
    • A01K1/0107A61F13/53
    • An ultra thin disposable pet pad may have a high pressure polyethylene cast film as a bottom layer, a non woven fabric as a top layer and a liquid absorbing material as a middle layer. The absorbent material may be a super absorbent polymer disposed between the top and bottom layers. The pet pad may be rolled for convenient storage and transportation. The absorbent material may extend to the edges of the top and bottom layers. The pet pad may be cut to size and re rolled for convenient carry.
    • 超薄一次性宠物垫可以具有作为底层的高压聚乙烯流延膜,作为顶层的无纺织物和作为中间层的液体吸收材料。 吸收材料可以是设置在顶层和底层之间的超吸收性聚合物。 宠物垫可以滚动以便于存储和运输。 吸收材料可以延伸到顶层和底层的边缘。 可以将宠物垫切割成大小并重新滚动以方便携带。
    • 54. 发明申请
    • Novel Salts Of Substituted 5-Membered Azacycle And Use Thereof In The Treatment Of Diseases Related To Protein Aging
    • 取代的5-Membership Azacycle的新型盐,并用于治疗与蛋白质老化有关的疾病
    • US20090227643A1
    • 2009-09-10
    • US12223236
    • 2007-01-29
    • Song LiHao CuiJunhai XiaoWu ZhongLili WangGang Cheng
    • Song LiHao CuiJunhai XiaoWu ZhongLili WangGang Cheng
    • A61K31/426C07D277/30A61P9/00
    • C07D277/62A23L3/3526
    • The present invention relates to 5-membered azacycle compounds of formula (I), pharmaceutically acceptable salts thereof and hydrates thereof, wherein the groups are as defined in the specification. The present invention further relates to pharmaceutical compositions containing said compounds or pharmaceutically acceptable salts thereof or hydrates thereof, and to use of the pharmaceutical compositions in (i) improving skin elasticity or reducing skin wrinkles, (ii) treating diabetes, (iii) treating or relieving adverse sequelae of diabetes, (iv) treating or relieving kidney damage, (v) treating or relieving damage to blood vasculature, (vi) treating or relieving hypertension, (vii) treating or relieving retinopathy, (viii) treating or relieving damage to lens proteins, (ix) treating or relieving cataract, (x) treating or relieving peripheral neuropathy, or (xi) treating or relieving osteoarthritis. The present invention further relates to use of said compounds or pharmaceutically acceptable salts thereof or hydrates thereof in the preparation of oral formulations for inhibiting or reversing tooth staining, or in the preparation of fresh-keeping agents for plant proteins of crops or animal proteins.
    • 本发明涉及式(I)的5元氮环化合物,其药学上可接受的盐及其水合物,其中基团如说明书中所定义。 本发明还涉及含有所述化合物或其药学上可接受的盐或其水合物的药物组合物,以及(i)改善皮肤弹性或减少皮肤皱纹,(ii)治疗糖尿病,(iii)治疗或 减轻糖尿病的不良后遗症,(iv)治疗或减轻肾脏损伤,(v)治疗或缓解血液血管系统的损害,(vi)治疗或缓解高血压,(vii)治疗或缓解视网膜病变,(viii)治疗或缓解损伤 (ix)治疗或缓解白内障,(x)治疗或缓解周围神经病变,或(xi)治疗或缓解骨关节炎。 本发明还涉及所述化合物或其药学上可接受的盐或其水合物在制备用于抑制或逆转牙齿染色的口服制剂中或在制备用于作物或动物蛋白质的植物蛋白质的保鲜剂中的用途。